We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-5.50 | -0.41% | 1,335.00 | 1,333.50 | 1,334.00 | 1,340.00 | 1,324.50 | 1,330.00 | 4,678,340 | 16:35:16 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1889 | 11.22 | 55.56B |
Date | Subject | Author | Discuss |
---|---|---|---|
05/1/2023 08:48 | So you keep saying Abdulla *yawn* | alibizzle | |
04/1/2023 16:12 | GSK is a direction less share | abdullla | |
04/1/2023 15:29 | I wish you had told me that this morning ?, will watch out for this. | l0ngterm | |
04/1/2023 15:20 | Pattern: If the price turns down in the afternoons, then buy before close. Next opening often sees it climb and reach a good height before (sell) Wall Street opens and watch the price tumble again before re-buying. | tradermichael | |
04/1/2023 09:50 | timothyo6 Post 31368 "Just because you’re mammy might have done that doesn’t mean everyone else’s did. You’re a scumbag of lowest degree" YOUR not You're And it's scumbag of the highest order, not lowest degree you muppet. bothdavis Post 31370 "appalling language, filtered......timoth Christ you're a sensitive soul! Appalling language? That's run of the mill banter compared to much vulgarity on Advfn. | geckotheglorious | |
03/1/2023 19:01 | Try being with this for 20+ years! ;)Sentiment here is dreadful but not without reason as they have serially disappointed, even within last few months. Be nice if the tide turns but will only do so if they start doing better with the pipeline.. | rikky72 | |
03/1/2023 16:46 | appalling language, filtered......timoth | bothdavis | |
03/1/2023 16:44 | Who to believe ? A few days ago people were saying buy. Now sell. Let's see what happens | alibizzle | |
03/1/2023 15:43 | Sorry - Fidepax1. I'm not going to spare a thought for you. Cant stand moaners. Buy a different share if you dont like this one. | netcurtains | |
03/1/2023 15:08 | Spare a thought for Emma Walsgrove? Odd I would have thought spare a thought for the long suffering shareholders. This morning JPMorgan downgraded the stock to 'underweight' from 'neutral', having reduced their corresponding target price from 1600 pence to 1350 pence. The broker said that it is concerned about the 'limited' earnings growth potential for 2023/2024, and a lack of promising projects in the drug development pipeline. Nothing much achieved for the shareholders in 5 years, limited pipeline development, expensive demerger but no value unlocked for shareholder, share price below where it started 5 years ago. Abysmal. 5 years is now too long with that record. | fidepax1 | |
03/1/2023 12:21 | TraderMichael Post 31362 "Don't seem to be able to get Shingrix on prescription :0(" Must be pricey! NHS prefers spending £50-60,000pa on diversity officers or £75,000-£100,000 on a director of talent management, or £100-110,000 pa on a Director for LIVED EXPERIENCE whatever the hell that is, than using money ot give patients treatments. | geckotheglorious | |
03/1/2023 12:13 | Your post here has dropped the share price by 10p . | abdullla | |
02/1/2023 13:56 | Don't seem to be able to get Shingrix on prescription :0( | tradermichael | |
02/1/2023 08:33 | Spare a thought for Dame Emma Walmsley, who has spent five years on a thankless clean-up job at Glaxosmithkline (big pay packets aside). When the chief executive arrived, GSK’s future medicines cupboard was looking bare and the business was bloated. Walmsley has tried to restore the company’s mojo by slashing costs, striking mega-deals and placing bets on cutting-edge science. This crescendoed with the separation of consumer business Haleon over the summer, leaving GSK focused on pure pharma. Yet the stock remains unloved, down 11pc this year compared to gains of around 30pc at archrival Astrazeneca. The malaise is partly due to legal claims over heartburn drug Zantac in the US. But a favourable court ruling has taken out much of the heat there. So at £14.58 per share, I think GSK is a bargain. The company’s Shingles vaccine, Shingrix, is delivering record sales once again. And it is leading the race to launch a jab for RSV, pending regulatory approval in the coming months, which could also deliver blockbuster sales. Perhaps 2023 is Dame Emma’s year. | zho | |
02/1/2023 08:27 | Put simply letsdothis is saying GLAXO and pharma are drug dealing scum then he pushes I gas!! Just shows how these weird people can happily push their own agenda. Fossil fuel extraction and burning is despised by some. Personally I sit on the fence with fossil fuels in cars as electric cars are not the answer. But back to glaxo .. | mattboxy | |
31/12/2022 14:44 | The healthcare sector is a sensible place to hunt for opportunities and pharmaceuticals group GSK is an attractive stock trading on a cheap valuation. Its shares are on 9.9-times forecast earnings for 2023, lower than the FTSE 100's 13.7-times and well below peers.... | zho | |
30/12/2022 23:06 | mattboxy i assume you do not have a car or have central heating,no of course you dont!!! whats your name thunberg?? | lippy4 | |
30/12/2022 22:44 | GSK shares . Think you've been on the cider | alibizzle | |
30/12/2022 21:27 | Tulips or roses What are you talking about? | netcurtains | |
30/12/2022 21:05 | What are you talking about | alibizzle |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions